Science and Research

Reprogramming of tumor-associated macrophages by targeting beta-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer

Tumor-associated macrophages (TAMs) influence lung tumor development by inducing immunosuppression. Transcriptome analysis of TAMs isolated from human lung tumor tissues revealed an up-regulation of the Wnt/beta-catenin pathway. These findings were reproduced in a newly developed in vitro "trained" TAM model. Pharmacological and macrophage-specific genetic ablation of beta-catenin reprogrammed M2-like TAMs to M1-like TAMs both in vitro and in various in vivo models, which was linked with the suppression of primary and metastatic lung tumor growth. An in-depth analysis of the underlying signaling events revealed that beta-catenin-mediated transcriptional activation of FOS-like antigen 2 (FOSL2) and repression of the AT-rich interaction domain 5A (ARID5A) drive gene regulatory switch from M1-like TAMs to M2-like TAMs. Moreover, we found that high expressions of beta-catenin and FOSL2 correlated with poor prognosis in patients with lung cancer. In conclusion, beta-catenin drives a transcriptional switch in the lung tumor microenvironment, thereby promoting tumor progression and metastasis.

  • Sarode, P.
  • Zheng, X.
  • Giotopoulou, G. A.
  • Weigert, A.
  • Kuenne, C.
  • Gunther, S.
  • Friedrich, A.
  • Gattenlohner, S.
  • Stiewe, T.
  • Brune, B.
  • Grimminger, F.
  • Stathopoulos, G. T.
  • Pullamsetti, S. S.
  • Seeger, W.
  • Savai, R.
Publication details
DOI: 10.1126/sciadv.aaz6105
Journal: Sci Adv
Pages: eaaz6105 
Number: 23
Work Type: Original
Location: CPC-M, UGMLC
Disease Area: LC
Partner / Member: HGMU, JLU, MPI-BN
Access-Number: 32548260
See publication on PubMed

DZL Engagements

chevron-down